Prescriber organizations meet on May 12 regarding the State of Ohio Board of Pharmacy (SOBP) changes to terminal distributor of dangerous drugs (TDDD) licensure and compounding rules.
While the SOBP has delayed application of the rule change pending additional discussion at its June 2016 meeting, prescriber organizations met to strategize on what needed to be done prior to that meeting in June.
It was decided, because the impact of the rule change is so different depending upon the prescriber, that each of the prescriber organizations would send a letter outlining their specific concerns.
View the Ohio Academy of Family Physicians’ letter dated May 17, 2016, authored by OAFP President Tom Houston, MD.
For more information, visit the OAFP website and watch future issues of the Weekly Family Medicine Update for updates.